Plain-English translation of NCT06794606 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study for adults with focal epilepsy — seizures that start in one area of the brain — that haven't responded well to medication. The study uses advanced imaging and diagnostic methods to understand exactly where seizures are coming from, and then helps determine the best treatment option for each person, which might include surgery, newer minimally invasive procedures, or other specialized approaches.
About one in four people with focal epilepsy don't respond to standard anti-seizure medications, and this condition severely impacts quality of life and can increase health risks. This study exists to help doctors better identify where seizures originate and match patients with the most effective and safest treatment for their specific situation.
You likely qualify if…
You likely don't qualify if…
While the specific details of visits aren't fully outlined in this summary, participants would likely undergo advanced brain imaging and diagnostic testing to pinpoint where their seizures originate. Based on the results, doctors would then discuss treatment options with you, which could range from medication adjustments to surgical or minimally invasive procedures. The study involves working closely with a specialized epilepsy team over several months to find the best path forward for your individual situation.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy